Pseudomembranous Colitis following Bortezomib Therapy in a Myeloma Patient

Publisher： Karger

E-ISSN： 1421-9662|117|4|211-214

ISSN： 0001-5792

Source： Acta Haematologica, Vol.117, Iss.4, 2007-01, pp. : 211-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-10 ,pp. : 184-188

Karger

Access to resources Recommend Favorite

Cytomegalovirus reactivation accompanied by varicella zoster virus reactivation or reinfection in an adult patient of multiple myeloma during bortezomib therapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 108-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical management of fulminant pseudomembranous colitis

By Boyer Alexandre   Thiery Guillaume   Pigne Etienne   De Lassence Arnaud  

Intensive Care Medicine, Vol. 27, Iss. 2, 2001-02 ,pp. : 445-445

Springer Publishing Company

Access to resources Recommend Favorite

RAS mutation status and bortezomib therapy for relapsed multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 905-908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bortezomib‐thalidomide‐dexamethasone versus bortezomib‐cyclophosphamide‐dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 605-606

John Wiley & Sons Inc

Access to resources Recommend Favorite